Abstract:Abstract Background The purpose of this study was to investigate the ability of differential diagnosis of prostate specific antigen decline rate (PSADR) per week, degree of prostatic collapse (DPC) and tissue signal rate of prostate (TSRP) between prostatitis and prostate cancer. Methods The clinical data of 92 patients [prostate specific antigen (PSA) > 10 ng/mL] who underwent prostate biopsy in the Department of Urology, the Second Affiliated Hospital of Xi ’an Jiaotong University from May 2017 to April 2020 were reviewed retrospectively. They were divided into two groups, prostatitis group ( n = 42) and prostate cancer (PCa) group ( n = 50), according to pathological results. Parameters, like patient characteristics, PSADR, DPC, TSRP and infectious indicators, were compared and analyzed by t test or non-parametric test to identify if there were significant differences. The thresholds of parameters were determined by the receiver operating characteristic curve (ROC), and the data were analyzed to investigate the diagnostic value in distinguishing of prostatitis and prostate cancer. Results There were statistical differences in age, PSADR, DPC, TSRP, neutrophil percentage in serum, white blood cell (WBC) in urine and prostate volume between prostatitis group and PCa group ( P < 0.001, < 0.001, = 0.001, 0.001, 0.024, 0.014, < 0.001 respectively). There was no statistical difference in serum WBC count, serum neutrophil count, monocyte percentage and urine bacterial count between two groups ( P = 0.089, 0.087, 0.248, 0.119, respectively). Determined by ROC curve, when the thresholds of PSADR per week as 3.175 ng/mL/week, DPC as 1.113, TSRP as 2.708 were cutoffs of distinguishing prostatitis and prostate cancer. When combining these three indexes to diagnose, the accuracy rate of diagnosis of prostatitis was 78.85%, the accuracy rate of diagnosis of prostate cancer was 97.50%. Univariate analysis suggested that PSADR, DPC and TSRP played an important role in differentiating prostate cancer from prostatitis ( P 3.175 might be good indicators when distinguishing prostate disease with prostatitis (OR = 14.305, 95%CI = 3.779 ~ 54.147), while DPC > 1.113 and TSRP > 2.708 might be associated with a higher risk of prostate cancer (OR = 0.151, 95%CI = 0.039 ~ 0.588; OR = 0.012, 95%CI = 0.005 ~ 0.524, respectively). Conclusion The combination of PSADR per week, DPC, and TSRP might be helpful to distinguish prostate cancer and prostatitis, and can reduce unnecessary invasive and histological procedure.

Comparative study of trace metal concentration in the diagnosis of category III prostatitis

Diagnostic potential of trace metals concentration in expressed prostatic secretion and serum of patients with category IV prostatitis

Prostatic Calculi Influence the Antimicrobial Efficacy in Men with Chronic Bacterial Prostatitis

Effect of Hypertension on Bacteria Composition of Prostate Biopsy in Patients with Benign Prostatic Hyperplasia and Prostate Cancer in PSA Grey-Zone.

Literature Study on Correlation Between TCM Syndromes of Chronic Prostatitis and Prostate Palpation

ocal Syndrome Differentiation in Diagnosis and Treatment of Chronic Prostatitis

Preliminary study of the effects of pathogens on chronic prostatitis

Comparison of cytokine levels in prostatic secretion between the IIIa and IIIb subtypes of prostatitis

Is type III prostatitis also associated with bacterial infection?

A preliminary study on the diagnostic value of PSADR, DPC and TSRP in the distinction of prostatitis and prostate cancer

Multi-factors including Inflammatory/Immune, Hormones, Tumor-related Proteins and Nutrition associated with Chronic Prostatitis NIH IIIa+b and IV based on FAMHES project

Multi-Factors Including Inflammatory/Immune, Hormones, Tumor-Related Proteins And Nutrition Associated With Chronic Prostatitis Nih Iiia Plus B And Iv Based On Famhes Project

Sexual dysfunctions and psychological disorders associated with type IIIa chronic prostatitis: a clinical survey in China

Study of iron metabolism based on T2* mapping sequences in PI-RADS 3 prostate lesions

Re-evalutation of diagnosis and treatment of chronic prostatitis

Gut microbiome in men with chronic prostatitis/chronic pelvic pain syndrome: profiling and its predictive significance

Quantitative Analysis of Incidentally Detected Prostate Carcinoma and Prostate Cancer in the Central Gland of Prostate with MRS

MRS in the Differential Diagnosis of Low T2 Signal Diseases in Peripheral Zone of Prostate: Prostatitis and Prostatic Carcinoma

Study on correlation between MR spectroscopy and whole pathologic seetion in benign prostatic hyperplasia

Detection Rate of Benign Prostatic Hyperplasia with Histological Prostatitis: Comparison Between Two Different Diagnostic Standards

Urinary metal and metalloid biomarker study of Henoch-Schonlein purpura nephritis using inductively coupled plasma orthogonal acceleration time-of-flight mass spectrometry